v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 161 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Revenue      
Sales     $ 2,994,931
Cost of sales     3,325,639
Gross Loss     (330,708)
Operating Expenses      
Depreciation     52,694
Selling, general and administration 155,824 115,860 12,650,979
Market development 42,562 3,381 728,077
Product development costs 122,075 59,700 3,546,090
Professional fees 40,343 82,410 1,930,748
Total Operating Expenses 360,804 261,351 18,908,588
Operating Loss (360,804) (261,351) (19,239,296)
Other Expenses (Income)      
Interest expenses 482,689 1,703,954 18,793,515
Write down of equipment     36,623
Other expenses (income) (40,228) 466 265,895
Total Other Expenses 442,461 1,704,420 19,096,033
Net Loss $ (803,265) $ (1,965,771) $ (38,335,329)
Loss per share, basic and diluted (in Dollars per share) $ 0.00 $ 0.01  
Weighted average shares outstanding, - basic and diluted (in Shares) 213,977,909 213,558,731